Natamycin
(NCXMLFZGDNKEPB-FFPOYIOWSA-N)
Structure
- SMILES
- C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@H]([C@@H]([C@@H]2O)N)O)C[C@@H]2O[C@@](C[C@H](C[C@@H]3[C@@H](/C=C/C(=O)O1)O3)O)(O)C[C@@H]([C@H]2C(=O)O)O
- Type(s)
- Approved
- ATC code(s)
- A01AB10; A07AA03; D01AA02; G01AA02; S01AA10
- Molecular Formula:
- C33H47NO13
- Molecular Weight:
- 665.725
- Log P:
- 0.8200
- Hydrogen Bond Acceptor:
- 14
- Hydrogen Bond Donor:
- 7
- TPSA:
- 230.99
- CAS Number(s):
- 7681-93-8
Synonym(s)
1.
Natamycin
2.
Pimaricin
3.
Tennecetin
4.
Myprozine
5.
Pimafucin
External Link(s)
| MeSH | D010866 |
| PubChem Compound | 5284447 |
| BindingDB | 50370755 |
| CHEMBL | CHEMBL1200656 |
| DrugBank | DB00826 |
| DrugCentral | 1885 |
| KEGG | cpd:C08073 dr:D00884 |
| ZINC | 8220909 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Product contamination microbial | FAERS: 5 | US FAERS | |
| 2 | Drug ineffective | FAERS: 1 | US FAERS | |
| 3 | Medication residue present | FAERS: 1 | US FAERS | |
| 4 | Burning sensation | Canada Vigilance: 1 | Canada Vigilance | |
| 5 | Chest Pain | SIDER | ||
| 6 | Chromoblastomycosis | 15905955 | CTD | |
| 7 | Conjunctivitis | Canada Vigilance: 1 | Canada Vigilance | |
| 8 | Corneal Diseases | 15905955 | CTD | |
| 9 | Corneal Opacity | SIDER | ||
| 10 | Eye irritation | SIDER | ||
| 11 | Eye pain | SIDER | ||
| 12 | Hypersensitivity | SIDER | ||
| 13 | Keratitis | 12149384 19654512 | CTD | |
| 14 | Kidney Diseases | 22863853 | CTD | |
| 15 | Lacrimation | SIDER | ||
| 16 | Mycoses | 12149384 | CTD | |
| 17 | Necrosis | 22863853 | CTD | |
| 18 | Ocular discomfort | SIDER |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.